clofazimine has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basson, K; Kriegler, A; van der Walt, BJ; van Zyl, JM | 1 |
| Anderson, R; O'Sullivan, JF; Zeis, BM | 1 |
| Anderson, R; Krajewska, MM; O'Sullivan, JF | 1 |
3 other study(ies) available for clofazimine and mocetinostat
| Article | Year |
|---|---|
Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chlorides; Chromatography, High Pressure Liquid; Clofazimine; Dapsone; Humans; Hydrogen Peroxide; Hypochlorous Acid; NAD; Neutrophils; Oxidation-Reduction; Peroxidase; Thyroglobulin | 1991 |
Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.
Topics: Clofazimine; Humans; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Peroxidase; Phenazines; Superoxides | 1987 |
Effects of clofazimine analogues and tumor necrosis factor-alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro.
Topics: Adult; Cell Degranulation; Clofazimine; Drug Synergism; Humans; In Vitro Techniques; Iodine; Neutrophils; Peroxidase; Superoxides; Tumor Necrosis Factor-alpha | 1993 |